Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04755283
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-10
First Post:
2021-02-11
Brief Title:
Safety and Tolerability of Abelacimab MAA868 vs Rivaroxaban in Patients With Atrial Fibrillation
Sponsor:
Anthos Therapeutics Inc
Organization:
Anthos Therapeutics Inc
Organization Data
Organization:
Anthos Therapeutics Inc
Class:
INDUSTRY
Study ID:
ANT-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Anthos Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Fortrea | INDUSTRY |
| The TIMI Study Group | OTHER |